Company intelligence / Profile preview

ABI-LAB

Natick, Massachusetts, United Statesabi-lab.com ↗

Ownership: Private
Development stage: Other

Overview

ABI-LAB operates as an accelerator and bio-incubator supporting over 30 life science startups and established companies. Its tenants have collectively raised over $3.3B in funding since 2022 and created more than 400 jobs locally, with additional job creation from graduate companies. The facility supports research in immunology, oncology, regenerative medicine, diagnostics, and precision medicine.

Therapeutic areas: Other
Modalities: Not applicable
Industry: Investors

Partnerships

At least ten partnerships with industry stakeholders are noted but specific names are not listed publicly

Beyond the preview

Go deeper on ABI-LAB.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABI-LAB.

Explore the full profile